Key points are not available for this paper at this time.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained use primarily due to their weight-reduction effects, although a regulatory review was undertaken for potential suicidality concern.
Building similarity graph...
Analyzing shared references across papers
Loading...
Schoretsanitis et al. (Tue,) studied this question.
synapsesocial.com/papers/68e5b89bb6db64358755109f — DOI: https://doi.org/10.1001/jamanetworkopen.2024.23385
Georgios Schoretsanitis
Stefan Weiler
University Hospital of Bern
Corrado Barbui
University of Verona
JAMA Network Open
ETH Zurich
University of Zurich
University of Bern
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: